Related Experiment Videos
Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy
G R Thomas1, J Greenberg, K T Wu
1Head and Neck Tumor Biology Section, NIDCD/NIH, Bethesda, Maryland, USA.
The Laryngoscope
|August 1, 1997
Summary
Planned early neck dissection is safe for head and neck squamous carcinoma patients with incomplete response after chemotherapy. This approach does not negatively impact recurrence or survival rates in organ preservation protocols.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Cancer Research
Background:
- Optimal management of advanced neck metastases in head and neck squamous carcinoma (HNSC) within organ preservation strategies remains unclear.
- A modified management paradigm incorporates planned early neck dissection for patients with incomplete nodal response after induction chemotherapy (IC).
Purpose of the Study:
- To evaluate the safety and efficacy of planned early neck dissection for advanced nodal disease in HNSC organ preservation.
- To determine if planned early neck dissection impacts recurrence, complications, or survival rates.
Main Methods:
- Retrospective analysis of 58 consecutive advanced HNSC patients in organ preservation trials.
- Patients received induction chemotherapy (IC) followed by radiation therapy with surgical salvage.
- Group analysis based on nodal response (complete response [CR] vs. less than CR) to IC.
Main Results:
- 49% of patients achieved CR of neck nodes after IC; 51% required planned early neck dissection.
- No significant differences observed in recurrence patterns, complications, or survival rates between CR and less than CR groups.
- Median follow-up was 26 months, with 71% of patients presenting at Stage IV.
Conclusions:
- Planned early neck dissection for HNSC patients with less than CR after IC is not detrimental to neck relapse or overall survival.
- This approach can be safely integrated into future organ preservation treatment protocols for advanced HNSC.
- Early neck dissection offers a viable option for managing advanced nodal disease in organ preservation settings.